How much funding has REVERAGEN BIOPHARMA, INC. raised?

REVERAGEN BIOPHARMA, INC. has raised $15.3M in total funding, most recently a Grant round.

When was REVERAGEN BIOPHARMA, INC. founded?

REVERAGEN BIOPHARMA, INC. was founded in 2015.

Where is REVERAGEN BIOPHARMA, INC. headquartered?

REVERAGEN BIOPHARMA, INC. is headquartered in Vienna, Virginia, United States.

What industry is REVERAGEN BIOPHARMA, INC. in?

REVERAGEN BIOPHARMA, INC. operates in Biotech, Healthcare.

How many employees does REVERAGEN BIOPHARMA, INC. have?

REVERAGEN BIOPHARMA, INC. has 1-10 employees.

REVERAGEN BIOPHARMA, INC.

Home - ReveraGen BioPharma

Vienna, United States · Founded 2015 · $15.3M raised

Biotech

Healthcare

Headquarters: Vienna, Virginia
Employees: 1–10
Founded: 2015
Business Model: B2B

Website: reveragen.com
Total Funding: $15.3M
Last Round: $3.3M GrantDec 2020

About

ReveraGen BioPharma is a clinical-stage drug development company focused on therapeutics for neuromuscular and inflammatory diseases. Its flagship product vamorolone (brand name AGAMREE), a dissociative steroid with a corticosteroid-like mechanism but improved safety profile, received FDA and EMA approval in 2023 for treating Duchenne muscular dystrophy. ReveraGen operates under a venture philanthropy model, returning a majority of revenues to non-profit muscular dystrophy foundations.

Summary

REVERAGEN BIOPHARMA, INC. is a Biotech company based in Vienna, United States, founded in 2015. It has raised $15.3M in total, most recently a $3.3M Grant round in Dec 2020.